1. TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT.
- Author
-
Zou Z, Zheng B, Li J, Lv X, Zhang H, Yu F, Kong L, Li Y, Yu M, Fang L, and Liang B
- Subjects
- Bile Duct Neoplasms mortality, Bile Duct Neoplasms pathology, Cell Cycle Proteins genetics, Cell Line, Tumor, Cholangiocarcinoma mortality, Cholangiocarcinoma pathology, Female, Humans, Kaplan-Meier Estimate, Male, Microtubule-Associated Proteins genetics, Middle Aged, Neoplasm Invasiveness, Nuclear Proteins genetics, Apoptosis genetics, Bile Duct Neoplasms metabolism, Cell Cycle Proteins metabolism, Cell Proliferation genetics, Cholangiocarcinoma metabolism, Epithelial-Mesenchymal Transition genetics, Microtubule-Associated Proteins metabolism, Nuclear Proteins metabolism
- Abstract
Purpose: The molecular signatures of cholangiocarcinoma are not well characterized. Targeting protein for Xenopus kinesin-like protein 2 (TPX2) has been shown to promote oncogenesis in the context of several cancers; however, its' role in cholangiocarcinoma has not been studied. We evaluated the role of TPX2 in cholangiocarcinoma., Methods: Expression levels of TPX2 in cholangiocarcinoma were assessed by immunohistochemistry. Potential correlations were assessed by Chi-squared test. Impact of TPX2 expression on cell proliferation, cell cycle, apoptosis, cell invasion and migration was investigated by CCK-8, flow cytometric analysis, and transwell assay, respectively. The expressions of cell-cycle, cell-apoptosis and EMT related target proteins were detected by immunoblotting., Results: TPX2 expression in cholangiocarcinoma tissues was significantly higher than that paracancerous tissue (44.3% vs. 5.7%; P<0.01). Overexpression of TPX2 showed a positive correlation with TNM stage, lymph node metastasis, and prognosis of patients. Knockdown of TPX2 expression induced G2-M arrest, apoptosis and inhibited invasion and migration of cholangiocarcinoma cells. Treatment of cholangiocarcinoma cells with TPX2 siRNA resulted in upregulation of cyclin A1, cyclin B1, p53, Bax, and E-cadherin; while downregulation of cyclin D1, CDK2, Bcl-2, N-cadherin, β-cadherin MMP-2, MMP-9, Slug, and Twist1., Conclusions: Collectively, these results indicate that TPX2 may serve as a potential biomarker of prognostic relevance and a potential therapeutic target for cholangiocarcinoma., (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF